The CTR Core serves as the central Mid-Atlantic NORC resource to facilitate the conduct of clinical research in nutrition and physical activity, seminal areas of investigation necessary to promote changes in the obesogenic American environment that will reduce the prevalence and ultimately prevent obesity. The multidisciplinary skills of the CTR Core's leadership assist Mid-Atlantic NORC investigators with study design, utilization of the wide range of state-of-the-art obesity, nutritional, metabolic and CVD-related research tests and interventions, and the development of collaborations. We promote the bi-directional translation of research from clinical experiences to the identification of genes that influence susceptibility to obesity and associated comorbidities in the Molecular Genetics and Nutrigenomics Core (MGN Core), and then probe the molecular and cellular mechanisms of obesity, type 2 diabetes and associated diseases in the Adipocyte Biology and Basic Mechanisms Core (ABBM Core) (Figure 1). We then assist investigators in the phenotyping of subjects, cardiometobolic evaluations, and the development and implementation of evidence-based diet, exercise and pharmacological interventions that can be translated into clinical trials in the community, and disseminated as real worid outcomes into practice (Figure 2).

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK072488-10
Application #
8733159
Study Section
Special Emphasis Panel (ZDK1-GRB-2)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
10
Fiscal Year
2014
Total Cost
$264,839
Indirect Cost
$73,167
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Montasser, May E; O'Hare, Elizabeth A; Wang, Xiaochun et al. (2018) An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels. Circulation 138:1343-1355
Taylor, Simeon I (2018) GLP-1 receptor agonists: differentiation within the class. Lancet Diabetes Endocrinol 6:83-85
Blau, Jenny E; Bauman, Viviana; Conway, Ellen M et al. (2018) Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight 3:
Geng, Xin; Irvin, Marguerite R; Hidalgo, Bertha et al. (2018) An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort. J Lipid Res 59:722-729
Ryan, Alice S; Serra, Monica C; Goldberg, Andrew P (2018) Metabolic Benefits of Prior Weight Loss with and without Exercise on Subsequent 6-Month Weight Regain. Obesity (Silver Spring) 26:37-44
Mitchell, Braxton D; Kalra, Gurmannat; Ryan, Kathleen A et al. (2018) Increased usual physical activity is associated with a blunting of the triglyceride response to a high-fat meal. J Clin Lipidol :
Differding, Moira K; Mueller, Noel T (2018) Are household disinfectants microbially mediated obesogens? CMAJ 190:E1095-E1096
Blau, Jenny E; Taylor, Simeon I (2018) Adverse effects of SGLT2 inhibitors on bone health. Nat Rev Nephrol 14:473-474
Serra, Monica C; Ryan, Alice S; Ortmeyer, Heidi K et al. (2018) Resistance training reduces inflammation and fatigue and improves physical function in older breast cancer survivors. Menopause 25:211-216
Oates, Connor P; Koenig, Darya; Rhyne, Jeffrey et al. (2018) Novel polymorphisms associated with hyperalphalipoproteinemia and apparent cardioprotection. J Clin Lipidol 12:110-115

Showing the most recent 10 out of 488 publications